← brief for 2026-08-19 · Slowing decline

A Study to Learn About How a New Nurandociguat Tablet is Absorbed and Processed in the Body Compared to an Old Tablet and How Food Affects the Way the New Tablet is Absorbed and Processed in the Body

Key takeaways

Researchers are testing a new pill form of a drug called nurandociguat, which is being developed for chronic kidney disease (long-term loss of kidney function, often from high blood sugar). This early study checks how the body takes in the new pill compared with an older one, and whether eating changes that. It is just starting, so there are no results yet on whether the drug helps kidneys.

Who did this work

Run by Bayer.
Sites: CRS Clinical Research Services Berlin GmbH

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-08-19
https://clinicaltrials.gov/study/NCT07722585